New MRI scanner could spot fake tumor growth in brain cancer patients
NCT ID NCT07443176
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new type of MRI called Field-Cycling Imaging (FCI) to see if it can tell the difference between real tumor growth and pseudo-progression (which looks like tumor but isn't) in adults with glioblastoma. Eighteen patients will get both a standard MRI and an FCI scan before, during, and after chemotherapy. The goal is to find better imaging markers to guide treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could give doctors a better way to tell if a glioblastoma is really growing or just showing treatment-related changes, helping guide treatment decisions.
- What could go wrong
- This is a very small, early study (18 people) that only tests imaging, not a treatment. The new MRI method may not prove reliable enough for routine use.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOM WHO GRADE 4 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Aberdeen
Aberdeen, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- AI reads brain scans to spot deadly tumors without surgery
- Artificial intelligence reads brain scans to detect deadly tumors
- Targeted radiation zaps glioblastoma cells after surgery
- New study aims to ease burden on families of brain injury patients
- MRNA vaccines take on glioblastoma: a new hope against brain cancer recurrence?